| Literature DB >> 34723979 |
Lidia Redondo-Bravo1, Beatriz Fernandez-Martinez2,3, Diana Gómez-Barroso2,3, Alin Gherasim4, Montserrat García-Gómez4, Agustín Benito1,5, Zaida Herrador2,5.
Abstract
INTRODUCTION: Scabies is a neglected disease stablished worldwide with a fairy well determined incidence. In high-income countries, it often causes outbreaks affecting the residents and staff of institutions and long-term facilities, usually hard to detect and control due to the difficult diagnosis and notification delay. This study aim at characterizing the affected population, geographical distribution, and evolution of scabies in Spain from 1997-2019 as well as to describe the main environments of transmission using different data sources.Entities:
Mesh:
Year: 2021 PMID: 34723979 PMCID: PMC8559925 DOI: 10.1371/journal.pone.0258780
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
General description of CMBD, RENAVE, BDCAP and CEPROSS databases.
| CMBD 1997–2017 | RENAVE 2011–2019 | BDCAP 2011–2017 | ODR 2007–2019 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N = 2.530 | n° | freq. | Average Annual CI | N = 5.125 | n° | freq. | Average Annual CI | N = 152.974 | n° | freq. | Average Annual CI | N = 1.357 | n° | freq. | Average Annual CI |
|
| 3 (95%CI: 2–3) |
| 13 (95%CI: 12–14) |
| 488 (95%CI: 482–494) |
| 2 (95%CI: 2–3) | ||||||||
|
|
|
|
|
|
|
|
| ||||||||
| 0–14 | 650 | 25.7% | 5 (95%CI: 3–6) | 0–14 | 452 | 8.8% | 8 (95%CI: 6–10) | | 38040 | 24.9% | 829 (95%CI: 806–851) | 0–14 | 0 | 0.0% | 0 (95%CI: 0–0) |
| 15 a 24 | 182 | 7.2% | 2 (95%CI: 1–3) | 15 a 24 | 260 | 5.1% | 6 (95%CI: 4–8) | 15 a 24 | 24146 | 22.3% | 666 (95%CI: 644–688) | 15 a 24 | 92 | 6.8% | 1 (95%CI: 0–2) |
| 25 a 44 | 552 | 21.8% | 2 (95%CI: 1–3) | 25 a 44 | 512 | 10.0% | 4 (95%CI: 3–5) | 25 a 44 | 38960 | 25.9% | 394 (95%CI: 384–405) | | 654 | 48.2% | 4 (95%CI: 3–5) |
| 45 a 64 | 403 | 15.9% | 2 (95%CI: 1–2) | 45 a 64 | 349 | 6.8% | 3 (95%CI: 2–5) | 45 a 64 | 34157 | 15.4% | 439 (95%CI: 426–451) | | 607 | 44.7% | 4 (95%CI: 3–5) |
| | 743 | 29.4% | 5 (95%CI: 3–6) | | 1031 | 20.1% | 15 (95%CI: 12–17) | ≥65 | 17671 | 11.6% | 324 (95%CI: 311–336) | ≥65 | 0 | 0.0% | 0 (95%CI: 0–0) |
|
|
| ||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||
| Female | 1064 | 58.0% | Female | 1475 | 51.8% | Female | 74147 | 48.5% | Female | 1083 | 79.8% | ||||
| Male | 1466 | 42.0% | Male | 912 | 38.2% | Male | 78827 | 51.5% | Male | 274 | 20.2% | ||||
|
|
|
| |||||||||||||
|
|
| 49 | 1.0% |
|
| ||||||||||
| Home | 2393 | 89.7% |
| 2 | 0.0% | ≥100.000 €/yr | 0 | 0.0% | Healthcare | 475 | 35.0% | ||||
| Death | 85 | 3.2% | mean | median | 18.000–99.999 €/yr | 19093 | 13.0% | Social services | 527 | 38.8% | |||||
| Others | 189 | 7.1% | 39.7 | 26.7 | <18.000 €/yr | 107471 | 73.2% | General administration | 263 | 19.4% | |||||
| min | max | Very low | 18798 | 12.8% | Education & Public order | 22 | 1.6% | ||||||||
| 0.4 | 100 | Unclassified | 389 | 0.3% | Others | 70 | 5.2% | ||||||||
|
| mean | sd |
|
| mean | sd | |||||||||
| HIV+ | 274 | 10.8% | 59.9 | 79.6 | Active | 40238 | 27.4% | 6.1 | 20.8 | ||||||
| Neoplasms | 171 | 6.8% | p25 | 8 | Unemployed | 16205 | 11.0% | p25 | 0 | ||||||
| Skin and subcutaneous tissue | 394 | 15.6% | p50 | 32 | Non-active | 63731 | 43.4% | p50 | 0 | ||||||
| Musculoskeletal.s /connective t. | 163 | 6.4% | p75 | 77 | Pensioner | 22911 | 15.6% | p75 | 7 | ||||||
| Immunosuppressive drugs | 10 | 0.4% | Other status | 3495 | 2.4% | ||||||||||
aAverage Annual CI (Cumulative Incidence): Average number of scabies cases identified annually in each data source per million inhabitants (CMBD.RENAVE.BDCAP) /per million active population (ODR)
bRent and employment status data are available from 2012 (in 2011 n = 6.093 unclassified)
cVery low refers to people earning money by other activities different from work in a very precarious context.
Number of outbreaks declared to RENAVE, cases and average cases by outbreak place of occurrence, from 2001 until 2019 in Spain.
| Settings and other places where outbreaks occurred | N. of outbreaks | % | N. of cases | % | Average cases by outbreak |
|---|---|---|---|---|---|
| Education centres | 44 | 6.5% | 285 | 5.6% | 6 |
| Probation and handicapped centres | 58 | 8.6% | 450 | 8.8% | 8 |
| Healthcare settings | 19 | 2.8% | 323 | 6.3% | 17 |
| Military barracks | 2 | 0.3% | 114 | 2.2% | 57 |
| Prisons | 6 | 0.9% | 37 | 0.7% | 6 |
| Homes | 330 | 49.1% | 1326 | 25.9% | 4 |
| Nursing homes | 145 | 21.6% | 2029 | 39.6% | 14 |
| Others | 44 | 6.5% | 337 | 6.6% | 8 |
| Unknown | 24 | 3.6% | 224 | 4.4% | 9 |
|
|
|
|
|
Fig 1No. of outbreaks, no. of cases and average cases per outbreak by setting/place of occurrence by RENAVE outbreaks data.
Fig 2Secondary attack rates and outbreaks length by setting/place of occurrence.
Fig 3Work-related scabies cases by setting type and occupation.
Dot´s size represents the number work-related scabies cases. HCW: Healthcare workers.
Fig 4Scabies annual admissions joinpoint regression model by HIV status and HIV+/HIV- scabies admissions ratio, from 1997–2017 in Spain.
APC: Annual percentage change.
Fig 5Annual average scabies cases/million inhabitants, from 2011–2017 in Spain by CMBD, RENAVE (outbreaks), BDCAP and ODR.
*Cases according to each database: CMBD: Scabies related admissions/million inhabitants. RENAVE: Scabies cases detected in outbreaks/million inhabitants. BDCAP: Scabies cases diagnosed in Primary Care/million inhabitants. ODR: Occupational scabies cases/million active population.
Spearman´s Rho correlation test between all scabies databases combinations by AA.CC, from 2011 to 2017 in Spain.
| Databases | Spearman´s Rho | p-value |
|---|---|---|
| CMBD-ODR | 0.66 |
|
| ODR-RENAVE | 0.42 | 0.10 |
| CMBD-BDCAP | 0.23 | 0.38 |
| CMBD-RENAVE | 0.45 | 0.07 |
| RENAVE-BDCAP | 0.27 | 0.31 |
| CEPROSS-BDCAP | 0.13 | 0.62 |
Fig 6